Trials / Completed
CompletedNCT02293967
Mass Balance Study of MT-1303
An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C] MT-1303 After a Single Oral Dose to Healthy Male Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the absorption, metabolism and excretion of MT-1303 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-1303 |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-11-19
- Last updated
- 2015-03-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02293967. Inclusion in this directory is not an endorsement.